Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127855-10-000209
Filing Date
2010-06-02
Accepted
2010-06-02 18:03:44
Documents
1
Period of Report
2010-05-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5726
  Complete submission text file 0001127855-10-000209.txt   7456
Mailing Address LEXINGTON AVENUE SUITE 120 HOLLYWOOD CA 90038
Business Address LEXINGTON AVENUE SUITE 120 HOLLYWOOD CA 90038 (323) 790-1717
IMARX THERAPEUTICS INC (Issuer) CIK: 0001123695 (see all company filings)

EIN.: 860974730 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 99 NAVAJO LANE TOPANGA CA 90290
Business Address
Takats Joseph Richard (Reporting) CIK: 0001489800 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33043 | Film No.: 10873926